Regulation challenge of tissue engineering and regenerative medicine in China

Regulation challenge of tissue engineering and regenerative medicine in China

The current regulatory status in the USA, European Union (EU), Japan, and China, associated with the clinical application of tissue engineering and regenerative medicine is presented. It is found that similar regulatory framework has been constructed in the USA and EU, in which risk-based regulatory...

Full description

Bibliographic Details
Main Authors: Liang Chen, Chunren Wang, Tingfei Xi
Format: Article
Language:English
Published: Oxford University Press 2013-09-01
Series:Burns & Trauma
Subjects:
Regenerative medicine
tissue engineering
medical product
regulation
technique
Online Access:http://www.burnstrauma.com/article.asp?issn=2321-3868;year=2013;volume=1;issue=2;spage=56;epage=62;aulast=Chen

Internet

http://www.burnstrauma.com/article.asp?issn=2321-3868;year=2013;volume=1;issue=2;spage=56;epage=62;aulast=Chen

Similar Items